CClinicalTrials.gg
CompletedNCT00685048Updated Apr 9, 2019

Brief Therapies for Problem Gambling Substance Abusers

An interventional study of 10 minutes of psycho-education and 10 minutes of brief advice in Gambling, sponsored by UConn Health. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-04-09.

Sponsored by UConn Health · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This project evaluates the efficacy of brief interventions for individuals seeking treatment for substance use disorders who also have gambling problems. In total, 220 problem gambling substance abusers will be randomized to one of three conditions: (a) a control condition consisting of 10 minutes of psychoeducation about gambling, (b) 10 minutes of brief advice about problem gambling and how to reduce it, or (c) four session of motivational and cognitive-behavioral therapy. Gambling, substance use and psychosocial problems will be assessed using standardized instruments at pre-treatment, month 2, 5, 8, 12, 16, 20 and 24-month follow-up evaluations.

02

Conditions studied

  • Gambling

Keywords

  • Gambling
  • Brief Therapies
  • Substance Abuse
03

In context

Drug Misuse

71 studies on the registry are indexed under Drug Misuse; 5 are open to participants now.

This study's enrollment of 220 is above the median of 151 across 56 interventional studies indexed under Drug Misuse.

Browse Drug Misuse studies →

Lead sponsor

UConn Health is the lead sponsor of 182 studies on the registry; 18 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age > 18 years
  • current (past-year) DSM-IV criteria for alcohol, cocaine, opioid or marijuana abuse or dependence
  • score >3 on the past-two month SOGS
  • report an average of >2 gambling days per month for the past 2 months; (e) spent an average of >$50/month on gambling in the past 2 months
  • English speaking
  • sign informed consent.

Exclusion criteria

Exclusion Criteria:

  • have uncontrolled major psychiatric disorders other than substance use that require inpatient hospitalization (e.g., active bipolar disorder, psychosis, suicidality)
  • desire specific gambling treatment or are currently receiving treatment for gambling
  • have severe cognitive impairment
  • read below 5th grade level
  • plan to relocate >100 miles or are likely to be incarcerated
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
220 participants (actual)

Study arms

  • Experimental
    1

    psychoeducation

    Behavioral: 10 minutes of psycho-education

  • Experimental
    2

    brief advice

    Behavioral: 10 minutes of brief advice

  • Experimental
    3

    Motivational Enhancement Therapy (MET)/Cognitive-Behavioral Therapy (CBT)

    Behavioral: four 50-minute individual therapy sessions of MET & CBT

Interventions

  • Behavioral10 minutes of psycho-education

    Patients review with study therapist a brochure about types of gambling people engage in and relationships between gambling, drug use, moods, and legal problems.

  • Behavioral10 minutes of brief advice

    Patients will review with study therapist a brochure and advice about problem gambling. It will also contain methods for reducing gambling.

  • Behavioralfour 50-minute individual therapy sessions of MET & CBT

    MET \& CBT

06

What researchers measure

Primary outcomes

  1. dollars and days gambled per month

    Time frame: baseline and each follow-up

07

Study locations

1 site
  • University of Connecticut Health Center
    Farmington, Connecticut 06030, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00685048
Lead sponsor
UConn Health
Collaborators
National Institute on Drug Abuse (NIDA)
Responsible party
Sponsor
First posted
May 28, 2008
Start date
Jul 2007
Primary completion
Jan 2014
Completion
Jan 2014
Last update
Apr 9, 2019

Study contacts

Nancy M Petry, Ph.D.
principal investigator · UConn Health Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion